EndoGastric Solutions recently debuted its EsophyX Z+ device, which is designed for use in transoral incisionless fundoplication procedures. 1. The device aids in the reconstruction of the ...
(and 43 states providing coverage). “The robust body of clinical evidence which supports the TIF 2.0 or discontinue PPI use and want a less invasive procedure than traditional surgery has access to ...
EndoGastric Solutions will present new data on the company’s Transoral Incisionless Fundoplication procedure for the treatment of gastroesophageal reflux disease at the Digestive Disease Week 2016 ...
SOUTH JORDAN, Utah, March 27, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (MMSI), a global leader of healthcare technology, announced today that the American Society for Gastrointestinal ...
Merit Medical Systems, Inc. MMSI recently executed an asset purchase agreement with EndoGastric Solutions, Inc. Per the terms, EndoGastric Solutions’ EsophyX Z+ device will become part of Merit ...
Merit Medical Systems Inc. acquired the Esophyx Z+ device from Endogastric Solutions Inc. for $105 million in cash, adding a durable, non-pharmacological treatment for gastroesophageal reflux disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback